Kistler Andreas D
Klinik für Nephrologie, Universitätsspital Zürich.
Praxis (Bern 1994). 2013 Oct 2;102(20):1229-35. doi: 10.1024/1661-8157/a001429.
Diabetic Nephropathy is the most common cause of end stage renal disease in Western countries. An increased urinary albumin excretion represents a characteristic sign of diabetic kidney damage. Regular screening for microalbuminuria allows early detection and timely intervention. In overt diabetic nephropathy, quantification of albuminuria helps monitoring disease progression. Therapeutic interventions to reduce albuminuria retard progression of nephropathy and reduce cardiovacular mortality, since albuminuria represents an independent cardiovascular risk factor. This review article describes the natural history of diabetic nephropathy and discusses practical issues for the measurement of albuminuria. Available prophylactic and therapeutic measures, particularly glycemic control and inhibition of the renin-angiotensin-aldosteron system, are reviewed using an evidence based approach.
糖尿病肾病是西方国家终末期肾病最常见的病因。尿白蛋白排泄增加是糖尿病肾损伤的一个特征性表现。定期筛查微量白蛋白尿可实现早期发现和及时干预。在显性糖尿病肾病中,蛋白尿的定量有助于监测疾病进展。降低蛋白尿的治疗性干预可延缓肾病进展并降低心血管死亡率,因为蛋白尿是一个独立的心血管危险因素。这篇综述文章描述了糖尿病肾病的自然病程,并讨论了蛋白尿测量的实际问题。采用循证医学方法对现有的预防和治疗措施,尤其是血糖控制和肾素 - 血管紧张素 - 醛固酮系统抑制进行了综述。